4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow fexapotide: new trials by email Literature Review of fexapotide trials Research Report on fexapotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) NX-1207 - Benign Prostatic Hyperplasia, BPH | Phase 3 | Completed | Nymox Corporation | 160 | 2013-04-01 | 2017-03-10 |
| Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX-1207 - Benign Prostatic Hyperplasia | Phase 3 | Completed | Nymox Corporation | 192 | 2011-09-01 | 2014-04-30 |
| Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 NX-1207, Placebo - Benign Prostatic Hyperplasia (BPH) | Phase 3 | Completed | Nymox Corporation | 500 | 2009-05-01 | 2017-03-10 |
| Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX-1207, Placebo - Benign Prostatic Hyperplasia | Phase 3 | Completed | Nymox Corporation | 500 | 2009-04-01 | 2014-04-30 |
Prostatic Hyperplasia (4) · Lower Urinary Tract Symptoms (2) · Urinary Bladder Neck Obstruction (2)
United States (4)